ABCA1-Gen
Das ABCA1-Gen ist ein membranständiges Transportprotein, welches insbesondere für den Cholesterintransport zuständig ist. Mutationen zeigen eine codominante Vererbung. Während heterozygote Anlageträger deutlich erniedrigte HDL-Werte aufweisen und damit ein deutlich erhöhtes Coronarrisiko besitzen, erkranken homozygote oder compound heterozygote Anlageträger an einer Tangier-Erkrankung.
Gentests:
Klinisch |
Untersuchungsmethoden |
Familienuntersuchung |
Bearbeitungszeit |
5 Tage |
Probentyp |
genomische DNS |
Verknüpfte Erkrankungen:
Referenzen:
1. |
Kulozik AE et al. (1992) A deletion/inversion rearrangement of the beta-globin gene cluster in a Turkish family with delta beta zero-thalassemia intermedia.
|
2. |
Ho Hong S et al. (2002) Novel ABCA1 compound variant associated with HDL cholesterol deficiency.
|
3. |
Fitzgerald ML et al. (2002) Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I.
|
4. |
Ishii J et al. (2002) Clinical variant of Tangier disease in Japan: mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosis.
|
5. |
Guo Z et al. (2002) Double deletions and missense mutations in the first nucleotide-binding fold of the ATP-binding cassette transporter A1 ( ABCA1) gene in Japanese patients with Tangier disease.
|
6. |
Tanaka AR et al. (2003) Effects of mutations of ABCA1 in the first extracellular domain on subcellular trafficking and ATP binding/hydrolysis.
|
7. |
Wang N et al. (2003) A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I.
|
8. |
Cenarro A et al. (2003) A common variant in the ABCA1 gene is associated with a lower risk for premature coronary heart disease in familial hypercholesterolaemia.
|
9. |
Kolovou GD et al. (2003) Tangier disease with unusual clinical manifestations.
|
10. |
Neufeld EB et al. (2004) The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.
|
11. |
Nofer JR et al. (2004) Impaired platelet activation in familial high density lipoprotein deficiency (Tangier disease).
|
12. |
Wahrle SE et al. (2004) ABCA1 is required for normal central nervous system ApoE levels and for lipidation of astrocyte-secreted apoE.
|
13. |
Hirsch-Reinshagen V et al. (2004) Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain.
|
14. |
Cohen JC et al. (2004) Multiple rare alleles contribute to low plasma levels of HDL cholesterol.
|
15. |
Repa JJ et al. (2000) Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers.
|
16. |
Albrecht C et al. (2005) A novel missense mutation in ABCA1 results in altered protein trafficking and reduced phosphatidylserine translocation in a patient with Scott syndrome.
|
17. |
Katzov H et al. (2006) Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-beta 1-42 and plasma apolipoprotein levels.
|
18. |
Brunham LR et al. (2006) Intestinal ABCA1 directly contributes to HDL biogenesis in vivo.
|
19. |
Brunham LR et al. (2007) Beta-cell ABCA1 influences insulin secretion, glucose homeostasis and response to thiazolidinedione treatment.
|
20. |
Rayner KJ et al. (2010) MiR-33 contributes to the regulation of cholesterol homeostasis.
|
21. |
Yvan-Charvet L et al. (2010) ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation.
|
22. |
Brunham LR et al. (2011) Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans.
|
23. |
Rayner KJ et al. (2011) Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.
|
24. |
Jennings MW et al. (1985) Analysis of an inversion within the human beta globin gene cluster.
|
25. |
Luciani MF et al. (1994) Cloning of two novel ABC transporters mapping on human chromosome 9.
|
26. |
Hoop RC et al. (1994) Restoration of half the normal dystrophin sequence in a double-deletion Duchenne muscular dystrophy family.
|
27. |
Becq F et al. (1997) ABC1, an ATP binding cassette transporter required for phagocytosis of apoptotic cells, generates a regulated anion flux after expression in Xenopus laevis oocytes.
|
28. |
Decottignies A et al. (1997) Complete inventory of the yeast ABC proteins.
|
29. |
Wellington CL et al. (2002) ABCA1 mRNA and protein distribution patterns predict multiple different roles and levels of regulation.
|
30. |
Teslovich TM et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids.
|
31. |
Lu TT et al. (2000) Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.
|
32. |
Kathiresan S et al. (2008) Polymorphisms associated with cholesterol and risk of cardiovascular events.
|
33. |
Najafi-Shoushtari SH et al. (2010) MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis.
|
34. |
Brooks-Wilson A et al. (1999) Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency.
|
35. |
Marcil M et al. (1995) Severe familial HDL deficiency in French-Canadian kindreds. Clinical, biochemical, and molecular characterization.
|
36. |
Marcil M et al. (1999) Cellular cholesterol transport and efflux in fibroblasts are abnormal in subjects with familial HDL deficiency.
|
37. |
Goossens M et al. (1986) Isolated growth hormone (GH) deficiency type 1A associated with a double deletion in the human GH gene cluster.
|
38. |
Young SG et al. (1999) The ABCs of cholesterol efflux.
|
39. |
Bodzioch M et al. (1999) The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease.
|
40. |
Rust S et al. (1999) Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1.
|
41. |
Remaley AT et al. (1999) Human ATP-binding cassette transporter 1 (ABC1): genomic organization and identification of the genetic defect in the original Tangier disease kindred.
|
42. |
Langmann T et al. (1999) Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages.
|
43. |
Orsó E et al. (2000) Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice.
|
44. |
Zwarts KY et al. (2002) ABCA1 regulatory variants influence coronary artery disease independent of effects on plasma lipid levels.
|
45. |
Szakács G et al. (2001) Characterization of the ATPase cycle of human ABCA1: implications for its function as a regulator rather than an active transporter.
|
46. |
Huang W et al. (2001) Novel mutations in ABCA1 gene in Japanese patients with Tangier disease and familial high density lipoprotein deficiency with coronary heart disease.
|
47. |
Lapicka-Bodzioch K et al. (2001) Homogeneous assay based on 52 primer sets to scan for mutations of the ABCA1 gene and its application in genetic analysis of a new patient with familial high-density lipoprotein deficiency syndrome.
|
48. |
Singaraja RR et al. (2001) Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter containing liver X receptor response elements in intron 1.
|
49. |
Tanaka AR et al. (2001) Human ABCA1 contains a large amino-terminal extracellular domain homologous to an epitope of Sjögren's Syndrome.
|
50. |
Utech M et al. (2001) Accumulation of RhoA, RhoB, RhoG, and Rac1 in fibroblasts from Tangier disease subjects suggests a regulatory role of Rho family proteins in cholesterol efflux.
|
51. |
Zhao LX et al. (2000) Cloning, characterization and tissue distribution of the rat ATP-binding cassette (ABC) transporter ABC2/ABCA2.
|
52. |
Santamarina-Fojo S et al. (2000) Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter.
|
53. |
Pullinger CR et al. (2000) Analysis of hABC1 gene 5' end: additional peptide sequence, promoter region, and four polymorphisms.
|
54. |
McNeish J et al. (2000) High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1.
|
55. |
Lawn RM et al. (1999) The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway.
|
56. |
Orphanet article
Orphanet ID 159528
|
57. |
NCBI article
NCBI 19
|
58. |
OMIM.ORG article
Omim 600046
|
59. |
Wikipedia Artikel
Wikipedia DE (ABCA_1)
|
Update: 14. August 2020